Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel

About half of patients with metastatic breast cancer (mBC) have unresectable liver metastases (LMs) or liver-predominant disease (LPD). Unfortunately systemic chemotherapy has limited tumor response due to LMs are supplied by hepatic artery. Hepatic intra-arterial (HAI) have antitumor activity in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranieri, Girolamo, Marech, Ilaria, Porcelli, Mariangela, Giotta, Francesco, Palmiotti, Gennaro, Laricchia, Giuseppe, Fazio, Vito, Gadaleta, Cosmo Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814293/
https://www.ncbi.nlm.nih.gov/pubmed/29487726
http://dx.doi.org/10.18632/oncotarget.23793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814293/
https://www.ncbi.nlm.nih.gov/pubmed/29487726
http://dx.doi.org/10.18632/oncotarget.23793

Ejemplares similares